Short Interest in Ainos, Inc. (NASDAQ:AIMD) Rises By 258.0%

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 634,100 shares, an increase of 258.0% from the December 31st total of 177,100 shares. Approximately 14.5% of the company’s stock are sold short. Based on an average daily trading volume, of 621,400 shares, the short-interest ratio is currently 1.0 days.

Ainos Price Performance

AIMD stock traded down $0.03 during trading on Thursday, reaching $0.68. The company’s stock had a trading volume of 162,776 shares, compared to its average volume of 1,731,539. The company’s fifty day moving average is $0.54 and its 200-day moving average is $0.56. Ainos has a 1 year low of $0.40 and a 1 year high of $3.10. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.33) EPS for the quarter.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.